Status:
UNKNOWN
Epidemiology and Genetics of the Amyotrophic Lateral Sclerosis in the French West Indies
Lead Sponsor:
Centre Hospitalier Universitaire de la Guadeloupe
Conditions:
Amyotrophic Lateral Sclerosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The diagnosis and the follow-up of the patients reached of SLA is centralized, since a few years, at the the Caribbean Reference center of the rare neurological diseases (CERCA labélisé in 2006) in Ma...
Detailed Description
The amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by progressive muscular paralysis due to degeneration of motor neurons in the primary motor cortex, corticospinal p...
Eligibility Criteria
Inclusion
- Patient or third-party responsible for receiving information on the study and who signed informed consent ;
- Patient age over 18 years;
- Patient living in the Antilles;
- Patient with ALS or SLP (primary lateral sclerosis, pure central form of ALS).
Exclusion
- Patient non-affiliated to the social security scheme ;
- in case of difficulty of monitoring patient, exclusion of the longitudinal study.
Key Trial Info
Start Date :
May 13 2014
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 13 2023
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03367650
Start Date
May 13 2014
End Date
May 13 2023
Last Update
December 11 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital University Center of Pointe-à-Pitre
Pointe-à-Pitre, Guadeloupe, 97159
2
Hospital University Center of Martinique
Fort-de-France, Martinique, 97261